Patients with neuromyelitis optica spectrum disorder (NMOSD) are associated with adverse outcome after total hip arthroplasty: a matched case–control study

[1]  Zeqing Huang,et al.  Epidemiological Study Based on China Osteonecrosis of the Femoral Head Database , 2020, Orthopaedic surgery.

[2]  H. Choi,et al.  Bone health in neuromyelitis optica: Bone mineral density and fractures. , 2020, Multiple sclerosis and related disorders.

[3]  G. McGwin,et al.  Inhospital Complications of Patients With Neuromuscular Disorders Undergoing Total Joint Arthroplasty , 2019, The Journal of the American Academy of Orthopaedic Surgeons.

[4]  F. Haddad,et al.  Prevention of Dislocation After Total Hip Arthroplasty. , 2018, The Journal of arthroplasty.

[5]  C. Duncan,et al.  Total hip arthroplasty in patients with neuromuscular imbalance , 2018, The bone & joint journal.

[6]  J. Purtill,et al.  Survivorship and Outcomes in Patients With Multiple Sclerosis Undergoing Total Joint Arthroplasty. , 2017, The Journal of arthroplasty.

[7]  J. Jenny,et al.  Can a target zone safer than Lewinnek's safe zone be defined to prevent instability of total hip arthroplasties? Case-control study of 56 dislocated THA and 93 matched controls. , 2017, Orthopaedics & traumatology, surgery & research : OTSR.

[8]  Yaou Liu,et al.  Clinical Features of Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders , 2016, Chinese medical journal.

[9]  P. Franklin,et al.  Validation of the HOOS, JR: A Short-form Hip Replacement Survey , 2016, Clinical orthopaedics and related research.

[10]  M. Pagnano,et al.  What Safe Zone? The Vast Majority of Dislocated THAs Are Within the Lewinnek Safe Zone for Acetabular Component Position , 2016, Clinical orthopaedics and related research.

[11]  D. Wingerchuk.  Neuromyelitis optica: Effect of gender , 2009, Journal of the Neurological Sciences.

[12]  S. Olindo,et al.  Relapsing neuromyelitis optica: long term history and clinical predictors of death , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[13]  B. Weinshenker,et al.  The spectrum of neuromyelitis optica , 2007, The Lancet Neurology.

[14]  Y. Itoyama,et al.  Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis , 2007, Multiple sclerosis.

[15]  D. Wingerchuk.  Evidence for humoral autoimmunity in neuromyelitis optica , 2006, Neurological research.

[16]  R. Rabin,et al.  EQ-SD: a measure of health status from the EuroQol Group , 2001, Annals of medicine.

[17]  P C O'Brien,et al.  The clinical course of neuromyelitis optica (Devic’s syndrome) , 1999, Neurology.

[18]  J. Lewis,et al.  Dislocations after total hip-replacement arthroplasties. , 1978, The Journal of bone and joint surgery. American volume.

[19]  Sarah E Goglin,et al.  Neuromyelitis Optica. , 2017, Rheumatic diseases clinics of North America.

[20]  W. Carroll,et al.  Neuromyelitis Optica , 2010, Current treatment options in neurology.

[21]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[22]  D. Goodin,et al.  Neuromyelitis Optica , 2002, Seminars in neurology.